A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
about
Scavenger Receptors: Emerging Roles in Cancer Biology and ImmunologyThe haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavengingTWEAK and the progression of renal disease: clinical translationSoluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseTNF superfamily: a growing saga of kidney injury modulators.A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.Clinical significance of sCD163 and its possible role in asthma (Review).High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathy.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function.Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells.Development of an Fn14 agonistic antibody as an anti-tumor agent.HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels.Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasiaLigand-targeted theranostic nanomedicines against cancerEvaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease.A CCL24-dependent pathway augments eosinophilic airway inflammation in house dust mite-challenged Cd163(-/-) miceTWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injuryFn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targetingIs TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.The Crystal Structure of the Fifth Scavenger Receptor Cysteine-Rich Domain of Porcine CD163 Reveals an Important Residue Involved in Porcine Reproductive and Respiratory Syndrome Virus InfectionTNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in miceReduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk.Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.TWEAK as a target for therapy in systemic lupus erythematosus.Metacaspase-binding peptide inhibits heat shock-induced death in Leishmania (L.) amazonensis
P2860
Q26799114-7479E5EC-6C84-448E-92C9-F81FF81E64C1Q26864505-2645B61F-F80E-4AE1-B3ED-E897CDD053A4Q26996775-972E7985-EDD7-4E21-8DC7-4D4F3B8161F7Q27347256-BAF050FA-3479-4582-BAD4-927136FCDEB8Q30479123-E24FD1D7-4DBC-4B4E-A65A-40389C5AC635Q30496163-634725AE-12E5-404A-8E1D-6730F0B5E76AQ31152445-FD034124-4388-443F-9B34-B40A653876F7Q33605328-9270576A-C7B7-4EB2-81E1-DEC91F1FF237Q33674640-984C482D-298C-4F6B-ADF0-ED0AA97052FBQ33765551-5E22E4FE-C858-42E9-9EB6-2D8CC76BB190Q33893843-E7B8A366-2C16-401A-99BD-23DDBDC65C3BQ33916381-6D3B2D2F-A1EE-479D-9686-3D8B34611A2AQ34162346-4FF3AF9C-C2B8-453F-AF1F-13B9066DDA00Q34171150-3B6A80CB-50AC-4ED6-8653-9B91FF04D53AQ34348370-F4F0D0CA-74D4-41EF-B331-12407DCD9DAAQ34399571-02F10629-E862-428D-86F4-96D0AAFE07E4Q34450860-D6CEEBAF-1D67-4A6E-9C3E-4EF437D956EBQ34551960-5420A349-88D7-49D5-B0A5-1C75FB261507Q35010086-FDE2DE89-F37A-4963-A7A4-5505524C14F5Q35556794-7CFD8807-D65D-4D8C-9491-81068A239622Q35866999-ECCE7D60-7B12-4305-97E6-6934F9832AE4Q35893298-09347C91-CB8B-4AC7-A2CF-081897632C81Q35895637-0189E905-4358-4ADB-AEB9-9503C4505103Q35958888-2F475447-4F4F-42AD-90F8-822562B8DE2FQ36693322-6AEB540D-C56A-4542-B9D7-A8B5C32BC638Q36749651-0153F465-75D1-4C2D-9585-64A90A320392Q36943867-4150D138-50E0-41BA-810B-376CB2F06F74Q36992432-BCA807A7-DF92-4D82-A664-53A9C998775EQ37031812-729B3244-09E6-4614-9EDB-DF5849A5D3C7Q37071856-E5B1166F-0A04-45D6-B6E5-DBB2FB036C7CQ37135363-215B191E-0A62-4130-8426-94B1874DE4C1Q37415529-D744D9AA-2377-4314-A1C8-EA663D5BBB4CQ37415728-B6B4C2FA-2F34-43B9-BA10-B45F88FE4976Q37494039-B1D6E622-1915-414C-A3D2-C94FE2BA873DQ37593186-B10F5F74-A224-4122-AF7E-642E1F703BB7Q37623761-0EE78448-B4A1-4BA5-A2B7-DB52F7C012EDQ37681640-373814BD-92BE-4609-8383-E1BFCA39C2F8Q37690660-6270D39B-7519-4D55-8185-FDDBB88C735CQ37722596-6752141C-C72C-4ABF-ABFF-624BF1C02B37Q37745497-CEED13A3-2EB1-40BE-8349-91B4E1186893
P2860
A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A previously unrecognized prot ...... ntial biological implications.
@ast
A previously unrecognized prot ...... ntial biological implications.
@en
A previously unrecognized prot ...... ntial biological implications.
@nl
type
label
A previously unrecognized prot ...... ntial biological implications.
@ast
A previously unrecognized prot ...... ntial biological implications.
@en
A previously unrecognized prot ...... ntial biological implications.
@nl
prefLabel
A previously unrecognized prot ...... ntial biological implications.
@ast
A previously unrecognized prot ...... ntial biological implications.
@en
A previously unrecognized prot ...... ntial biological implications.
@nl
P2093
P1476
A previously unrecognized prot ...... ntial biological implications.
@en
P2093
Akihiko Kuniyasu
Bharat B Aggarwal
Jessica Sun
Laura C Bover
Marina Cardó-Vila
Motohiro Takeya
Roberto Rangel
Wadih Arap
P304
P356
10.4049/JIMMUNOL.178.12.8183
P407
P577
2007-06-01T00:00:00Z